NEW YORK, NY / ACCESS Newswire / February 8, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

Q4 2024 dividend of 16p declared; 61p FY 2024; 64p expected for 2025. GSK (GSK) now intends to commence a GBP 2B share buyback programme, to be implemented over the next 18 months. Published first ...

NYSE GSK opened at $34.91 on Tuesday. GSK plc has a 52 week low of $31.72 and a 52 week high of $45.92. The firm has a market capitalization of $72.34 billion, a P/E ratio of 22.67, a PEG ratio of ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

A task force has been set up to look into how to spend a £2m GSK legacy as the pharmaceutical giant closes its doors in Ulverston. Giles ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK launched a rare £2bn share buyback and raised its growth targets on the back of strong sales of ...

It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024. GSK has increased its long-term sales guidance amid hopes for a boost from new speciality medicines ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

GSK today increased its 2031 sales outlook to more than £40 billion, up from £38 billion amid stronger progress in its late-stage drugs pipeline. Total 2024 sales in GSK’s annual results published ...

On 16 January 2025, Mr Justice Mellor delivered a judgment in the High Court concerning a patent dispute between ... with Pfizer's expenses estimated at £6.312 million and GSK's at £3.67 million. The ...

high costs, and insurance to get access to treatments that can help them. Here’s the gist: An Amgen drug called Ravicti, which is approved to treat urea cycle disorders, has also been shown in ...